Literature DB >> 8550989

The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.

P D Siersema1, L H Rademakers, M I Cleton, F J ten Kate, W C de Bruijn, J J Marx, J H Wilson.   

Abstract

Porphyria cutanea tarda is a disorder of porphyrin metabolism, of which familial and sporadic forms have been described. Factors such as iron seem necessary for porphyria cutanea tarda to become clinically manifest. To study the relationship between iron and uroporphyrins in hepatocytes of patients with porphyria cutanea tarda, a morphological and morphometrical study was performed in 13 liver biopsies of patients with porphyria cutanea tarda (eight with sporadic porphyria cutanea tarda and five with familial porphyria cutanea tarda). In addition, possible differences in clinical and biochemical features and in histopathological findings between patients with sporadic porphyria cutanea tarda and familial porphyria cutanea tarda were investigated. Familial porphyria cutanea tarda patients presented at a younger age than sporadic porphyria cutanea tarda patients (42.4 +/- 5.3 vs. 57.3 +/- 8.6 years). Biochemical features were not different between sporadic porphyria cutanea tarda and familial porphyria cutanea tarda patients. Uroporphyrin crystals and a variable degree of liver siderosis were detected in the biopsies of all 13 patients. Uroporphyrin crystals were often found close to ferritin-like iron deposits. The morphometrical analysis showed that an increased mean area fraction of ferritin iron was associated with an increased mean area fraction of uroporphyrin crystals in hepatocytes of sporadic porphyria cutanea tarda and familial porphyria cutanea tarda patients. Moreover, the amount of uroporphyrin crystals was significantly higher in livers of familial porphyria cutanea tarda than sporadic porphyria cutanea tarda patients. These findings are consistent with the hypothesis that uroporphyria is precipitated by an iron-dependent process.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8550989

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  4 in total

1.  Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda.

Authors:  L Christiansen; A Bygum; A Jensen; K Thomsen; F Brandrup; M Hørder; N E Petersen
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

2.  Porphyrin loading of lipofuscin granules in inflamed striated muscle.

Authors:  C R Kiefer; J B McKenney; J F Trainor; R W Lambrecht; H L Bonkovsky; L M Lifshitz; C R Valeri; L M Snyder
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

Review 3.  Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias.

Authors:  Vaithamanithi-Mudumbai Sadagopa Ramanujam; Karl Elmo Anderson
Journal:  Curr Protoc Hum Genet       Date:  2015-07-01

4.  Liver cirrhosis induced by porphyria cutanea tarda: a case report and review.

Authors:  Kwang Gyun Lee; Jong Jin Hyun; Yeon Seok Seo; Bora Keum; Hyung Joon Yim; Yoon Tae Jeen; Hong Sik Lee; Hoon Jai Chun; Chang Duck Kim; Ho Sang Ryu; Soon Ho Um
Journal:  Gut Liver       Date:  2010-12-17       Impact factor: 4.519

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.